tiprankstipranks
Trending News
More News >
Champions Oncology (CSBR)
NASDAQ:CSBR
US Market

Champions Oncology (CSBR) Financial Statements

Compare
141 Followers

Champions Oncology Financial Overview

Champions Oncology's market cap is currently $94.30M. The company's EPS TTM is $0.06; its P/E ratio is 40.81; Champions Oncology is scheduled to report earnings on December 15, 2025, and the estimated EPS forecast is $0.09. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 56.94M$ 50.16M$ 53.87M$ 49.11M$ 41.04M
Gross Profit$ 26.91M$ 20.75M$ 24.34M$ 25.48M$ 19.59M
Operating Income$ 4.85M$ -6.92M$ -4.45M$ 607.00K$ 366.00K
EBITDA$ 6.29M$ -5.41M$ -2.07M$ 3.00M$ 2.02M
Net Income$ 4.70M$ -7.28M$ -5.33M$ 548.00K$ 362.00K
Balance Sheet
Cash & Short-Term Investments$ 9.79M$ 2.62M$ 10.12M$ 9.01M$ 4.69M
Total Assets$ 32.34M$ 26.13M$ 34.31M$ 35.38M$ 27.59M
Total Debt$ 6.11M$ 7.43M$ 8.60M$ 9.47M$ 9.60M
Net Debt$ -3.68M$ 4.81M$ -1.52M$ 459.00K$ 4.91M
Total Liabilities$ 28.57M$ 28.04M$ 29.68M$ 26.28M$ 20.16M
Stockholders' Equity$ 3.77M$ -1.90M$ 4.64M$ 9.10M$ 7.43M
Cash Flow
Free Cash Flow$ 7.00M$ -6.97M$ 1.08M$ 4.11M$ -4.96M
Operating Cash Flow$ 7.39M$ -6.14M$ 3.96M$ 6.50M$ -1.68M
Investing Cash Flow$ -389.00K$ -836.00K$ -2.87M$ -2.38M$ -3.17M
Financing Cash Flow$ 170.00K$ -527.00K$ 11.00K$ 207.00K$ 1.20M
Currency in USD

Champions Oncology Earnings and Revenue History

Champions Oncology Debt to Assets

Champions Oncology Cash Flow

Champions Oncology Forecast EPS vs Actual EPS